Schmid John P.
SEC insider (Form 3/4/5 filer). CIK 0001478916. Director at BlossomHill Therapeutics, Inc. (BLSM) and 6 other issuers. 63 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in SAN DIEGO, CA.
Companies Schmid John P. has filed insider reports for
- BlossomHill Therapeutics, Inc. (BLSM): Director
- First Tracks Biotherapeutics, Inc. (TRAX): Director
- ANAPTYSBIO, INC (ANAB): Director
- Design Therapeutics, Inc. (DSGN): Director
- Helix Acquisition Corp. III (HLXC): Director
- BridgeBio Oncology Therapeutics, Inc. (BBOT)
- Poseida Therapeutics, Inc. (PSTX): Director
Schmid John P.
CIK: 0001478916
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (63 total)
- Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
PurchaseDirect6K shares at avg. $16.00$96K - Jun 15, 2026TRAX
First Tracks Biotherapeutics, Inc.
ExerciseDirect6K shares- - Jun 15, 2026ANAB
ANAPTYSBIO, INC
ExerciseDirect6K shares- - Jun 9, 2026DSGN
Design Therapeutics, Inc.
AwardDirectStock Option (right to buy)
30K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectRestricted Stock Unit
2.5K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
7K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
42K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectRestricted Stock Unit
15K shares- - Apr 20, 2026ANAB
ANAPTYSBIO, INC
DispositionDirectStock Option (right to buy)
6K shares- - Apr 20, 2026ANAB
ANAPTYSBIO, INC
DispositionDirectStock Option (right to buy)
15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 |  BLSM BlossomHill Therapeutics, Inc. | Purchase | 6,000 | $16.00 | $96,000 | Direct |
| Jun 15, 2026 |  TRAX First Tracks Biotherapeutics, Inc. | Exercise | 6,030 | - | $0 | Direct |
| Jun 15, 2026 |  ANAB ANAPTYSBIO, INC | Exercise | 6,030 | - | $0 | Direct |
| Jun 9, 2026 |  DSGN Design Therapeutics, Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Restricted Stock Unit | 2,500 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 7,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 42,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Restricted Stock Unit | 15,000 | - | - | Direct |
| Apr 20, 2026 | ANAB ANAPTYSBIO, INC | Disposition Stock Option (right to buy) | 6,000 | - | - | Direct |
| Apr 20, 2026 | ANAB ANAPTYSBIO, INC | Disposition Stock Option (right to buy) | 15,000 | - | - | Direct |
1-10 of 63 transactions